drugset / Trial / NCT03594513

Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.

NCT03594513

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the present study is to compare two different multidisciplinary protocols using two types of grafts, porcine acellular dermal matrix (Mucoderm®) versus connective tissue graft, both associated with modified coronally advanced flap, in the treatment of multiple adjacent gingival recessions associated with non-carious cervical lesion partially (NCCL) restored by composite resin.

Timeline

Start
2018-07-02
Primary completion
2019-11-02
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Background Chlorhexidine Small molecule 0.12 %
Background dipyrone Unknown 500 mg

Indications